University of Michigan Surgical Oncology Research Training Program

摘要 密歇根大学外科肿瘤学研究培训项目 迫切需要外科肿瘤学家接受研究学科的培训。这次手术的目的是 肿瘤学研究培训计划旨在促进多产和成功的医生的发展 科学家。邹卫平，医学博士，查尔斯·德·南克里德病理学、免疫学、生物学教授， 和外科学以及Jacqueline Jeruss，医学博士，外科、病理学和生物医学工程学教授 担任本项目的联席主任。实习生将是外科住院医生，参加为期两年的奖学金。 该奖学金的具体目标是：1)设计、实施、分析和报告研究项目；2)获得 基础研究方法和临床研究/试验方面的指导；以及3)获得基础方面的指导 癌症生物学和免疫学，以及卫生服务研究原理。 密歇根大学罗杰尔癌症中心提供广泛的癌症相关研究 向学员提供实验室和项目。罗杰尔癌症中心是NCI指定的癌症中心 是美国国立卫生研究院研究经费排名前七的癌症中心之一。本培训计划内的所有讲师 是罗杰尔癌症中心的成员。这一方案得益于该部良好的记录 外科在吸引以学术为导向的外科住院医生方面的作用。每个学员都将被指派一名导师(S)来 在项目期间实施一项研究项目。该计划的课程包括广泛的教学重点 关于癌症生物学和免疫学的基本原理，以及针对学术的指导 职业发展。在负责任的研究行为方面的正式指导是必需的，并通过 这所大学。由国际知名的癌症临床护理和治疗专家组成的外部咨询委员会 已经招募了研究人员为这一重要计划提供指导和支持。 这一培训计划已经存在了六个资助期，跨度为30年。节目继续进行。 非常成功，从来没有空过，已经招收了61名实习生。在受训人员中，18%是 来自代表性不足的少数族裔群体的个人，36%是女性。根据2020年的一项研究， Demblowski等人。发现，截至2020年6月，只有0.7%的外科科学家持有NIH R赠款基金。 最近对以前学员的调查显示，47%的受访者接受了外部资金，89%的受访者报告 参与临床试验研究。在完成T32奖学金的45名学员中，他们的 在临床培训方面，87%受雇于学术/教学医院。Narahari等人。建议各机构和 NIH为外科医生-科学家提供更多的职业早期支持，以帮助外科医生-科学家的职业轨迹2 这一T32计划非常成功地实现了这一关键目标，即为年轻外科医生做好准备 非常成功的学术外科职业生涯。

Abstract University of Michigan Surgical Oncology Research Training Program There is a critical need for surgical oncologists to be trained in research disciplines. The purpose of this surgical oncology research training program is to foster the development of productive and successful physician scientists. Weiping Zou, M.D., Ph.D., the Charles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery and Jacqueline Jeruss, M.D., Ph.D., Professor of Surgery, Pathology, and Biomedical Engineering serve as Co-Directors of this program. Trainees will be surgical residents enrolled in a two-year fellowship. Specific aims of the fellowship are: 1) design, implement, analyze and report a research project; 2) obtain instruction on fundamental research methods and clinical studies/trials; and 3) obtain instruction on fundamental cancer biology and immunology, and health services research principles. The University of Michigan Rogel Cancer Center provides an extensive breadth of cancer-related research laboratories and programs to the trainees. The Rogel Cancer Center is an NCI-designated Cancer Center that is among the top 7 cancer centers in terms of NIH research funding. All preceptors within this training program are members of the Rogel Cancer Center. This program benefits from the strong track record of the Department of Surgery in attracting academically oriented surgical residents. Each trainee will be assigned a mentor(s) to implement a research project during the program. The program curriculum includes extensive instruction focused on fundamental cancer biology and immunology principles, as well as instruction directed towards academic career development. Formal instruction in the responsible conduct of research is required and provided through the University. An External Advisory Committee of internationally renowned experts in clinical cancer care and research has been enlisted to provide guidance and support for this important program. This training program has been in existence for six funding periods spanning 30 years. The program continues to be highly successful and has never gone unfilled, having enrolled 61 trainees. Of the trainees, 18% were individuals from underrepresented minority ethnic groups, and 36% were female. According to a 2020 study, Demblowski et al. found that, as of June 2020, only 0.7% of surgeon scientists held NIH R grant funding.1 A recent survey of prior trainees revealed that 47% of respondents received external funding and 89% reported involvement in clinical trials research. Among the 45 trainees who completed the T32 fellowship and their formal clinical training, 87% are employed at academic/teaching hospitals. Narahari et al. suggest institutions and the NIH provide increased early-career support to surgeon-scientists to assist surgeon-scientist career trajectories.2 This T32 program has been highly successful in meeting this critical objective of preparing young surgeons for highly successful academic surgical careers.